For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University of Oxford

Return to search Previous output Next output
Output 27 of 815 in the submission
Article title

A phase i study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

Type
D - Journal article
Title of journal
British Journal of Cancer
Article number
-
Volume number
104
Issue number
5
First page of article
750
ISSN of journal
0007-0920
Year of publication
2011
URL
-
Number of additional authors
14
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
D - (CAN) Cancer
Citation count
18
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-